Weight-loss surgery is more cost-effective than taking blockbuster GLP-1 drugs, delivering two more healthy years of life and saving patients about $9,000 a year, according to a new analysis.
Tina Reed is the Health Care Editor at Axios, where she covers the latest news and trends in the healthcare industry. Her reporting focuses on topics such as pharmaceutical developments, healthcare policy, and the impact of emerging technologies on the medical field. Tina's work has also been featured in various news outlets, including Yahoo News, FierceHealth, and RealClearHealth.